{"id":"https://openalex.org/W4385706503","doi":"https://doi.org/10.1097/01.hs9.0000967572.05685.92","title":"S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3","display_name":"S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3","publication_year":2023,"publication_date":"2023-08-01","ids":{"openalex":"https://openalex.org/W4385706503","doi":"https://doi.org/10.1097/01.hs9.0000967572.05685.92"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000967572.05685.92","doi":"https://doi.org/10.1097/01.hs9.0000967572.05685.92","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000967572.05685.92","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000967572.05685.92","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079124367","display_name":"Uwe Platzbecker","orcid":"https://orcid.org/0000-0003-1863-3239","observed_orcids":["https://orcid.org/0000-0003-1863-3239"]},"institutions":[{"id":"https://openalex.org/I4210125843","display_name":"University Hospital Leipzig","ror":"https://ror.org/028hv5492","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210125843"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Uwe Platzbecker","raw_affiliation_strings":["Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany","institution_ids":["https://openalex.org/I4210125843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091318797","display_name":"Valeria Santini","orcid":"https://orcid.org/0000-0002-5439-2172","observed_orcids":["https://orcid.org/0000-0002-5439-2172"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]},{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Valeria Santini","raw_affiliation_strings":["MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy","institution_ids":["https://openalex.org/I4210115393","https://openalex.org/I45084792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014838075","display_name":"Pierre Fenaux","orcid":"https://orcid.org/0000-0002-0468-3553","observed_orcids":["https://orcid.org/0000-0002-0468-3553"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Fenaux","raw_affiliation_strings":["Service d\u2019H\u00e9matologie S\u00e9niors, H\u00f4pital Saint-Louis, Universit\u00e9 de Paris 7, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d\u2019H\u00e9matologie S\u00e9niors, H\u00f4pital Saint-Louis, Universit\u00e9 de Paris 7, Paris, France","institution_ids":["https://openalex.org/I4210144610","https://openalex.org/I4387154366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055740968","display_name":"Mikkael Aaron Sekeres","orcid":"https://orcid.org/0000-0003-2009-6524","observed_orcids":["https://orcid.org/0000-0003-2009-6524"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]},{"id":"https://openalex.org/I4210157065","display_name":"Sylvester Comprehensive Cancer Center","ror":"https://ror.org/0552r4b12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I145608581","https://openalex.org/I4210101935","https://openalex.org/I4210157065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikkael Sekeres","raw_affiliation_strings":["Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Robert Savona","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, United States","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090985347","display_name":"Yazan F. Madanat","orcid":"https://orcid.org/0000-0001-9573-2690","observed_orcids":["https://orcid.org/0000-0001-9573-2690"]},"institutions":[{"id":"https://openalex.org/I4390039370","display_name":"Harold C. Simmons Comprehensive Cancer Center","ror":"https://ror.org/03cbz4r60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039370","https://openalex.org/I867280407"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yazan Madanat","raw_affiliation_strings":["Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, United States","institution_ids":["https://openalex.org/I4390039370","https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063154849","display_name":"Mar\u00eda D\u00edez\u2010Campelo","orcid":"https://orcid.org/0000-0002-1467-6779","observed_orcids":["https://orcid.org/0000-0002-1467-6779","https://orcid.org/0000-0003-0386-4835"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210099034","display_name":"Complejo Hospitalario de Salamanca","ror":"https://ror.org/0131vfw26","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda D\u00edez Campelo","raw_affiliation_strings":["Hematology Department, The University Hospital of Salamanca, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, The University Hospital of Salamanca, Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210099034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020211212","display_name":"David Valc\u00e1rcel","orcid":"https://orcid.org/0000-0002-8747-078X","observed_orcids":["https://orcid.org/0000-0002-8747-078X"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"David Valc\u00e1rcel","raw_affiliation_strings":["Hematology Department, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048469868","display_name":"Thomas Illmer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Illmer","raw_affiliation_strings":["Hematology Private Practice, Dresden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Private Practice, Dresden, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044809473","display_name":"Anna T Jonasova","orcid":"https://orcid.org/0000-0003-0246-1524","observed_orcids":["https://orcid.org/0000-0003-0246-1524"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Jon\u00e1\u0161ov\u00e1","raw_affiliation_strings":["1st Medical Department - Hematology, General Hospital, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Medical Department - Hematology, General Hospital, Prague, Czech Republic","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084726862","display_name":"Petra B\u011blohl\u00e1vkov\u00e1","orcid":"https://orcid.org/0000-0001-8728-7443","observed_orcids":["https://orcid.org/0000-0001-8728-7443"]},"institutions":[{"id":"https://openalex.org/I4210137570","display_name":"University Hospital Hradec Kr\u00e1lov\u00e9","ror":"https://ror.org/04wckhb82","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210137570"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Petra Belohlavkova","raw_affiliation_strings":["4th Department of Internal Medicine - Haematology, Charles University Hospital, Hradec Kralove, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4th Department of Internal Medicine - Haematology, Charles University Hospital, Hradec Kralove, Czech Republic","institution_ids":["https://openalex.org/I4210137570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062937325","display_name":"Laurie Jill Sherman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laurie Sherman","raw_affiliation_strings":["Geron Corporation, Parsippany, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Parsippany, United States","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113350088","display_name":"Tymara Berry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tymara Berry","raw_affiliation_strings":["Geron Corporation, Parsippany, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Parsippany, United States","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078437962","display_name":"Souria Dougherty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Souria Dougherty","raw_affiliation_strings":["Geron Corporation, Parsippany, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Parsippany, United States","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112781837","display_name":"Sheetal Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheetal Shah","raw_affiliation_strings":["Geron Corporation, Parsippany, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Parsippany, United States","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109737956","display_name":"Qi Xia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qi Xia","raw_affiliation_strings":["Geron Corporation, Parsippany, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Parsippany, United States","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054753060","display_name":"Lixian Peng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lixian Peng","raw_affiliation_strings":["Geron Corporation, Parsippany, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Parsippany, United States","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106038534","display_name":"Libo Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Libo Sun","raw_affiliation_strings":["Geron Corporation, Parsippany, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Parsippany, United States","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077959613","display_name":"Ying Wan","orcid":"https://orcid.org/0000-0001-5909-2892","observed_orcids":["https://orcid.org/0000-0001-5909-2892"]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying Wan","raw_affiliation_strings":["Geron Corporation, Parsippany, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Parsippany, United States","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062094994","display_name":"Fei Huang","orcid":"https://orcid.org/0000-0003-3263-0675","observed_orcids":["https://orcid.org/0000-0003-3263-0675"]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fei Huang","raw_affiliation_strings":["Geron Corporation, Parsippany, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Parsippany, United States","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109089705","display_name":"Annat F. Ikin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annat Ikin","raw_affiliation_strings":["Geron Corporation, Parsippany, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Parsippany, United States","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113348914","display_name":"Shyamala Chendeal Navada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shyamala Navada","raw_affiliation_strings":["Geron Corporation, Parsippany, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Parsippany, United States","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010075752","display_name":"Rami S. Komrokji","orcid":"https://orcid.org/0000-0002-1876-5269","observed_orcids":["https://orcid.org/0000-0002-1876-5269"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rami S. Komrokji","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, United States","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067521829","display_name":"Amer Methqal Zeidan","orcid":"https://orcid.org/0000-0001-7017-8160","observed_orcids":["https://orcid.org/0000-0001-7017-8160"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amer M. Zeidan","raw_affiliation_strings":["Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, United States","institution_ids":["https://openalex.org/I2802730090","https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":19,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":0.823,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.74001382,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"7","issue":"S3","first_page":"e0568592","last_page":"e0568592"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imetelstat","display_name":"imetelstat","score":0.9980000257492065},{"id":"https://openalex.org/keywords/telomerase-inhibitors","display_name":"telomerase inhibitors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/transfusion-independence","display_name":"transfusion independence","score":0.9120000004768372},{"id":"https://openalex.org/keywords/lower-risk-myelodysplastic-syndromes","display_name":"lower-risk myelodysplastic syndromes","score":0.9509999752044678},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.8399999737739563},{"id":"https://openalex.org/keywords/red-blood-cell-transfusion-dependence","display_name":"red blood cell transfusion dependence","score":0.8069999814033508},{"id":"https://openalex.org/keywords/ring-sideroblasts","display_name":"ring sideroblasts","score":0.8650000095367432},{"id":"https://openalex.org/keywords/variant-allele-frequency","display_name":"variant allele frequency","score":0.7300000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8270564675331116},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7108974456787109},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.632362425327301},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.5219592452049255},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.5077205896377563},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48004400730133057},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4672866463661194},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4481547772884369},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.41650527715682983},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3360663056373596},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2823209762573242},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.1991277039051056},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000967572.05685.92","doi":"https://doi.org/10.1097/01.hs9.0000967572.05685.92","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000967572.05685.92","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10428232","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10428232","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10428232/pdf/hs9-7-e0568592.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:b6444027c6ea4c15867cb6c56b608600","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b6444027c6ea4c15867cb6c56b608600","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 7, p e0568592 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000967572.05685.92","doi":"https://doi.org/10.1097/01.hs9.0000967572.05685.92","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000967572.05685.92","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386282370","https://openalex.org/W4310159715","https://openalex.org/W4379340614","https://openalex.org/W2951689340","https://openalex.org/W3165895858","https://openalex.org/W4389232365","https://openalex.org/W4389229209","https://openalex.org/W2953120750","https://openalex.org/W2984372424","https://openalex.org/W3097251831"],"abstract_inverted_index":{"Background:":[0],"Unmet":[1],"need":[2,536],"remains":[3],"for":[4,162,490],"novel":[5,538],"therapies":[6],"after":[7],"failure":[8],"of":[9,48,71,226,307,427,443,484,537],"erythropoiesis":[10],"stimulating":[11],"agents":[12,63],"(ESAs)":[13],"in":[14,38,75,79,145,240,268,356,361,366,398,410,535],"red":[15],"blood":[16],"cell":[17],"(RBC)":[18],"transfusion":[19,41,124,183],"dependent":[20],"(TD)":[21],"lower-risk":[22],"myelodysplastic":[23],"syndromes":[24],"(LR-MDS).":[25],"In":[26],"IMerge":[27,80,411],"Phase":[28,81],"2":[29,273],"(NCT02598661),":[30],"treatment":[31,522],"with":[32,233,253,259,322,326,369,394,419,440,464,518],"imetelstat,":[33],"a":[34,45,177,528],"telomerase":[35],"inhibitor,":[36],"resulted":[37],"prolonged,":[39],"durable":[40,473,508],"independence":[42],"(TI)":[43],"across":[44,237],"broad":[46],"range":[47],"heavily":[49,529],"RBC":[50,85],"TD":[51,86,530],"ESA":[52,87],"relapsed/refractory":[53],"non-del(5q)":[54,90],"LR-MDS":[55,91,478],"patients":[56],"(pts)":[57],"naive":[58,93],"to":[59,94,99,449,504,527],"lenalidomide":[60],"and":[61,69,126,139,170,185,195,342,385,423,431,437,446,460,468,472,501],"hypomethylating":[62],"(len/HMA).":[64],"Aims:":[65],"Evaluate":[66],"the":[67],"efficacy":[68,463],"safety":[70,406],"imetelstat":[72,101,215,234,254,277,292,310,323,333,370,420,436,441],"vs":[73,210,216,235,255,272,278,293,324],"placebo":[74,106,217,236,298],"this":[76,477],"pt":[77,295,533],"population":[78,534],"3.":[82],"Methods:":[83],"Heavily":[84],"relapsed/refractory/ineligible":[88],"(R/R)":[89],"pts":[92,208,212,270,274,289,367,486],"len/HMA":[95],"were":[96,174,320,408,421,433,442,516],"randomized":[97],"2:1":[98],"receive":[100],"7.5":[102],"mg/kg":[103],"(N=118)":[104],"or":[105],"(N=60)":[107],"every":[108],"4":[109,453],"wks.":[110,454],"The":[111,154,168,202,224,413],"primary":[112,155,169,203],"endpoint":[113,204],"was":[114,152,158,165,190,205,229,249,266,363],"8-wk":[115,219,227],"TI":[116,135,137,164,188,228,245,265,309,396,470,489],"rate;":[117],"subgroup":[118],"analyses":[119],"included":[120,133],"IPSS":[121,186],"risk,":[122],"prior":[123,182,519],"burden,":[125],"ring":[127],"sideroblasts":[128],"(RS)":[129],"status.":[130],"Secondary":[131],"endpoints":[132,173],"24-wk":[134],"rate,":[136],"duration,":[138,445],"hematologic":[140],"improvement-erythroid":[141],"(HI-E)":[142],"rate.":[143],"Change":[144],"mutation":[146],"burden":[147,184],"(variant":[148],"allele":[149],"frequency":[150],"[VAF])":[151],"exploratory.":[153],"analysis":[156],"cutoff":[157,161],"Oct":[159],"2022;":[160],"\u22651-yr":[163,300],"Jan":[166],"2023.":[167],"key":[171],"secondary":[172],"compared":[175,196],"using":[176],"Cochran-Mantel-Haenszel":[178],"test":[179],"stratified":[180,198],"by":[181,192,197],"category.":[187],"duration":[189,246,397],"calculated":[191],"Kaplan-Meier":[193],"method":[194],"log-rank":[199],"test.":[200],"Results:":[201],"met;":[206],"47":[207],"(39.8%)":[209],"9":[211],"(15.0%)":[213],"receiving":[214,276,332],"achieved":[218,267,299,487],"TI,":[220,301,509],"P":[221,261,280,302,328,401],"<":[222,262,281,329,340,375,402],"0.001.":[223,263,282,330,403],"rate":[225],"also":[230],"significantly":[231,335,364],"higher":[232,336],"subgroups,":[238],"including":[239,507],"RS":[241],"negative":[242],"pts.":[243],"Median":[244],"(95%":[247],"CI)":[248],"51.6":[250],"(26.9\u201383.9)":[251],"wks":[252,258],"13.3":[256],"(8.0\u201324.9)":[257],"placebo,":[260,279,327],"Twenty-four-wk":[264],"33":[269],"(28.0%)":[271],"(3.3%)":[275],"With":[283],"3":[284,357],"months\u2019":[285],"additional":[286],"follow-up,":[287],"21":[288],"(17.8%)":[290],"on":[291,297,352,435],"1":[294],"(1.7%)":[296],"=":[303,346,379,383,388],"0.002,":[304],"representing":[305,493],"63.6%":[306],"\u226524-wk":[308],"responders":[311],"(Figure).":[312],"HI-E":[313],"rates":[314,426,471],"(2018":[315],"IWG,":[316],"emphasizing":[317],">16-wk":[318],"response)":[319],"42.4%":[321],"13.3%":[325],"Pts":[331],"had":[334],"mean":[337],"hemoglobin":[338],"(P":[339,345,374,378,382,387],"0.001)":[341],"fewer":[343],"transfusions":[344],"0.042)":[347],"over":[348],"time":[349],"than":[350,371],"those":[351],"placebo.":[353,438],"VAF":[354,391,499],"reduction":[355,392,500],"genes":[358],"frequently":[359],"mutated":[360],"MDS":[362,532],"greater":[365],"treated":[368],"placebo:":[372],"SF3B1":[373,390],"0.001),":[376],"TET2":[377],"0.032),":[380],"DNMT3A":[381],"0.019)":[384],"ASXL1":[386],"NS).":[389],"correlated":[393],"longer":[395],"imetelstat-treated":[399,485],"pts,":[400],"No":[404],"new":[405],"signals":[407],"identified":[409],"P3.":[412],"most":[414],"common":[415],"Grade":[416,428,450],"3/4":[417],"AEs":[418],"thrombocytopenia":[422],"neutropenia;":[424],"similar":[425],"\u22653":[429],"bleeding":[430],"infections":[432],"observed":[434],"Cytopenias":[439],"short":[444],">80%":[447],"resolved":[448],"\u22642":[451],"within":[452],"Summary/Conclusion:":[455],"Imetelstat":[456,521],"demonstrated":[457],"statistically":[458],"significant":[459,524],"clinically":[461],"meaningful":[462],"robust":[465],"8-wk,":[466],"24-wk,":[467],"1-yr":[469],"continuous":[474,488],"TI.":[475],"For":[476],"patient":[479],"population,":[480],"almost":[481],"one":[482],"fifth":[483],"\u22651":[491],"yr,":[492],"substantial":[494],"relief":[495],"from":[496],"transfusion-associated":[497],"complications.":[498],"its":[502],"correlation":[503],"clinical":[505,525],"endpoints,":[506],"support":[510],"imetelstat\u2019s":[511],"disease-modifying":[512],"potential.":[513],"Safety":[514],"results":[515],"consistent":[517],"reports.":[520],"provides":[523],"benefit":[526],"LR":[531],"therapy.Keywords:":[539],"Therapy,":[540],"Clinical":[541],"trial,":[542],"Myelodysplastic":[543],"syndrome,":[544],"Telomerase":[545],"activity":[546]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-08-10T00:00:00"}